[HTML][HTML] RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific …, 2020 - eprints.gla.ac.uk
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
N Chegou, S Malherbe, F Darboe, M Erasmus… - Scientific …, 2020 - escholarship.org
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
[PDF][PDF] RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific …, 2020 - pure.mpg.de
Results Prognostic performance of RISK6 in the adolescent cohort study discovery cohort.
The RISK6 signature was discovered on samples from adolescent progressors and controls …
The RISK6 signature was discovered on samples from adolescent progressors and controls …
[引用][C] RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi… - Scientific …, 2020 - espace.library.uq.edu.au
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific …, 2020 - research.rug.nl
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi, E Thompson… - 2020 - bura.brunel.ac.uk
Results Prognostic performance of RISK6 in the adolescent cohort study discovery cohort.
The RISK6 signature was discovered on samples from adolescent progressors and controls …
The RISK6 signature was discovered on samples from adolescent progressors and controls …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
A Penn-Nicholson, SK Mbandi… - Scientific …, 2020 - scholarlypublications …
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
A Penn-Nicholson, SK Mbandi… - Scientific …, 2020 - researchonline.lshtm.ac.uk
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific …, 2020 - europepmc.org
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …